ConductScience.org, home

Paper134751

Fibrinolysis in normal plasma and blood: evidence for significant mechanisms independent of the plasminogen-plasmin system.

Moroz LA and 1 other. Blood, 1976. Cited by 44 papers, by iCite.

Cite this record

ConductScience Library. Fibrinolysis in normal plasma and blood: evidence for significant mechanisms independent of the plasminogen-plasmin system. Papers, record 134751. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/134751

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Fibrinolysis in normal plasma and blood: evidence for significant mechanisms independent of the plasminogen-plasmin system.
PubMed
Journal
Blood
PubMed
Year
1976
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
44
iCite
Relative citation ratio, by iCite
1.79
iCite
Revised in PubMed
2021-02-16
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Moroz LAL A
2Gilmore NJN J

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
FibrinolysinMajor topic
FibrinolysisMajor topic
PlasminogenMajor topic
Aminocaproates
Complement System Proteins
Edetic Acid
Egtazic Acid
Factor XII
Humans
Isoflurophate
Serum Globulins
Time Factors
Tosylarginine Methyl Ester
Tranexamic Acid
Urokinase-Type Plasminogen Activator

Source PubMed

Download CSV of topics

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 44 citations.

PMIDTitleJournalYearIn PapersSource
35677828Bleeding During Veno-Venous ECMO: Prevention and Treatment.Front Med (Lausanne)2022https://conductscience.org/library/papers/35677828PubMed
22451663Plasminogen is a complement inhibitor.J Biol Chem2012https://conductscience.org/library/papers/22451663PubMed
6448869Breakdown products of fibrin and fibrinogen: molecular mechanisms and clinical implications.J Clin Pathol Suppl (R Coll Pathol)1980https://conductscience.org/library/papers/6448869PubMed
310809Why do protease inhibitors enhance leucocyte migration inhibition to the antigen PPD?Immunology1978https://conductscience.org/library/papers/310809PubMed
111639Intravascular coagulation and fibrinolysis within primate extremities during tourniquet ischemia.Ann Surg1979https://conductscience.org/library/papers/111639PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
PLAU5328PubTator's text mininghttps://conductscience.org/library/genes/5328

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/134751

GET https://conductscience.org/api/papers/v1/134751/authors